scholarly article | Q13442814 |
P50 | author | Thomas G Beach | Q67218653 |
Bradley F Boeve | Q67501037 | ||
Dennis W. Dickson | Q30504740 | ||
Elizabeth Finger | Q42734328 | ||
Roberta Ghidoni | Q43188784 | ||
Luisa Benussi | Q43188790 | ||
Ronald C. Petersen | Q56839853 | ||
Marsel Mesulam | Q56862907 | ||
Eileen H Bigio | Q57020324 | ||
Minerva M Carrasquillo | Q59661913 | ||
Charles L White | Q60638965 | ||
David S Knopman | Q63967707 | ||
Zbigniew K Wszolek | Q64754704 | ||
Giuliano Binetti | Q64856448 | ||
P2093 | author name string | T Hunter | |
S G Younkin | |||
N Johnson | |||
D H Geschwind | |||
W W Seeley | |||
A Kertesz | |||
B L Miller | |||
M Baker | |||
R Rademakers | |||
G Coppola | |||
G Forloni | |||
I R Mackenzie | |||
J Gonzalez | |||
R Caselli | |||
R Crook | |||
N R Graff-Radford | |||
J Crook | |||
R Uitti | |||
N Finch | |||
C Lippa | |||
P Sengdy | |||
A M Karydas | |||
K J Hantanpaa | |||
M Dejesus-Hernandez | |||
N J Rutherford | |||
P2860 | cites work | Genetic variation in PCDH11X is associated with susceptibility to late-onset Alzheimer's disease | Q24610759 |
PLINK: a tool set for whole-genome association and population-based linkage analyses | Q24677407 | ||
Familial multiple system tauopathy with presenile dementia: a disease with abundant neuronal and glial tau filaments | Q24684804 | ||
Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21 | Q28253639 | ||
Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17 | Q28253651 | ||
Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17 | Q28274687 | ||
Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria | Q29614410 | ||
Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions | Q30434949 | ||
Accelerated lipofuscinosis and ubiquitination in granulin knockout mice suggest a role for progranulin in successful aging | Q33947272 | ||
Clinical and pathological diagnosis of frontotemporal dementia: report of the Work Group on Frontotemporal Dementia and Pick's Disease | Q33955976 | ||
Clinicopathological correlates in frontotemporal dementia | Q34345893 | ||
Prediction of pathology in primary progressive language and speech disorders. | Q35014616 | ||
Progranulin (granulin-epithelin precursor, PC-cell-derived growth factor, acrogranin) mediates tissue repair and tumorigenesis | Q35203303 | ||
Clinical and pathological characterization of progressive aphasia | Q36351816 | ||
Progranulin functions as a neurotrophic factor to regulate neurite outgrowth and enhance neuronal survival | Q36527176 | ||
The genetics of frontotemporal lobar degeneration | Q36926070 | ||
The molecular genetics and neuropathology of frontotemporal lobar degeneration: recent developments | Q36931728 | ||
Common variation in the miR-659 binding-site of GRN is a major risk factor for TDP43-positive frontotemporal dementia | Q36967985 | ||
Frontotemporal dementia: clinicopathological correlations | Q37069848 | ||
Loss of progranulin function in frontotemporal lobar degeneration | Q37105126 | ||
Plasma progranulin levels predict progranulin mutation status in frontotemporal dementia patients and asymptomatic family members | Q37148011 | ||
Gene expression study on peripheral blood identifies progranulin mutations | Q37411590 | ||
Low plasma progranulin levels predict progranulin mutations in frontotemporal lobar degeneration. | Q40051471 | ||
Conversion of proepithelin to epithelins: roles of SLPI and elastase in host defense and wound repair | Q40677795 | ||
Tau is a candidate gene for chromosome 17 frontotemporal dementia | Q42456776 | ||
Missense mutations in the progranulin gene linked to frontotemporal lobar degeneration with ubiquitin-immunoreactive inclusions reduce progranulin production and secretion. | Q51973117 | ||
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 467-474 | |
P577 | publication date | 2010-12-22 | |
P1433 | published in | Neurology | Q1161692 |
P1476 | title | TMEM106B regulates progranulin levels and the penetrance of FTLD in GRN mutation carriers | |
P478 | volume | 76 |
Q64768946 | Q64768946 |
Q38841003 | "New Old Pathologies": AD, PART, and Cerebral Age-Related TDP-43 With Sclerosis (CARTS). |
Q47620193 | A Dementia-Associated Risk Variant near TMEM106B Alters Chromatin Architecture and Gene Expression. |
Q53691504 | A Novel Loss-of-Function GRN Mutation p.(Tyr229*): Clinical and Neuropathological Features. |
Q36775677 | Advances in understanding the molecular basis of frontotemporal dementia |
Q35160833 | Allelic expression of deleterious protein-coding variants across human tissues |
Q36121377 | Arizona Study of Aging and Neurodegenerative Disorders and Brain and Body Donation Program |
Q34500097 | Brain distribution of dipeptide repeat proteins in frontotemporal lobar degeneration and motor neurone disease associated with expansions in C9ORF72 |
Q38206207 | C9ORF72 hexanucleotide repeats in behavioral and motor neuron disease: clinical heterogeneity and pathological diversity |
Q29465782 | C9orf72 binds SMCR8, localizes to lysosomes, and regulates mTORC1 signaling |
Q39165154 | C9orf72: At the intersection of lysosome cell biology and neurodegenerative disease |
Q97535454 | CRISPR-based functional genomics for neurological disease |
Q92173373 | Characterization of lysosomal proteins Progranulin and Prosaposin and their interactions in Alzheimer's disease and aged brains: increased levels correlate with neuropathology |
Q39472371 | Circulating progranulin as a biomarker for neurodegenerative diseases |
Q35545502 | Differential clinicopathologic and genetic features of late-onset amnestic dementias |
Q48122054 | Distribution and characteristics of transactive response DNA binding protein 43 kDa pathology in progressive supranuclear palsy |
Q37609848 | Elevated TMEM106B levels exaggerate lipofuscin accumulation and lysosomal dysfunction in aged mice with progranulin deficiency |
Q37248850 | Epidemiology and genetics of frontotemporal dementia: a door-to-door survey in southern Italy. |
Q35063181 | Epigenetic dysregulation of hairy and enhancer of split 4 (HES4) is associated with striatal degeneration in postmortem Huntington brains |
Q37485507 | Expression of TMEM106B, the frontotemporal lobar degeneration-associated protein, in normal and diseased human brain |
Q38394075 | Frontotemporal Dementias |
Q26768177 | Frontotemporal Lobar Degeneration and MicroRNAs |
Q59800165 | Frontotemporal dementia causative CHMP2B impairs neuronal endolysosomal traffic-rescue by TMEM106B knockdown |
Q36073666 | Frontotemporal dementia caused by CHMP2B mutation is characterised by neuronal lysosomal storage pathology |
Q28081198 | Frontotemporal dementia: a bridge between dementia and neuromuscular disease |
Q37928504 | Frontotemporal dementia: from Mendelian genetics towards genome wide association studies |
Q35204586 | Frontotemporal lobar degeneration: defining phenotypic diversity through personalized medicine |
Q38040822 | Frontotemporal lobar degeneration: epidemiology, pathology, diagnosis and management |
Q38802501 | Gene regulation and genetics in neurochemistry, past to future. |
Q89438455 | Genetic Modifiers in Neurodegeneration |
Q38786774 | Genetics of FTLD: overview and what else we can expect from genetic studies |
Q34248849 | Genetics of dementia |
Q92477950 | Genome Wide Association Study and Next Generation Sequencing: A Glimmer of Light Toward New Possible Horizons in Frontotemporal Dementia Research |
Q34658391 | Genome-wide association studies in neurology |
Q28250864 | Hippocampal sclerosis in Lewy body disease is a TDP-43 proteinopathy similar to FTLD-TDP Type A |
Q37882469 | Human genetics as a tool to identify progranulin regulators |
Q90127184 | Impairment of Lysosome Function and Autophagy in Rare Neurodegenerative Diseases |
Q41455989 | Intracellular Proteolysis of Progranulin Generates Stable, Lysosomal Granulins that Are Haploinsufficient in Patients with Frontotemporal Dementia Caused by GRN Mutations |
Q55484201 | Longitudinal structural gray matter and white matter MRI changes in presymptomatic progranulin mutation carriers. |
Q48187381 | Loss of TMEM106B Ameliorates Lysosomal and Frontotemporal Dementia-Related Phenotypes in Progranulin-Deficient Mice. |
Q99420895 | Loss of TMEM106B potentiates lysosomal and FTLD-like pathology in progranulin-deficient mice |
Q55209391 | Loss of Tmem106b is unable to ameliorate frontotemporal dementia-like phenotypes in an AAV mouse model of C9ORF72-repeat induced toxicity. |
Q28585799 | Lysosome size, motility and stress response regulated by fronto-temporal dementia modifier TMEM106B |
Q36003800 | Membrane orientation and subcellular localization of transmembrane protein 106B (TMEM106B), a major risk factor for frontotemporal lobar degeneration |
Q64106726 | Microglial Progranulin: Involvement in Alzheimer's Disease and Neurodegenerative Diseases |
Q39035458 | Molecular Genetics of Neurodegenerative Dementias |
Q26766487 | Molecular Pathways Bridging Frontotemporal Lobar Degeneration and Psychiatric Disorders |
Q37235164 | Novel progranulin mutations with reduced serum-progranulin levels in frontotemporal lobar degeneration |
Q92606686 | Omics in Neurodegenerative Disease: Hope or Hype? |
Q50980787 | Optimal plasma progranulin cutoff value for predicting null progranulin mutations in neurodegenerative diseases: a multicenter Italian study. |
Q55439517 | Partial Tmem106b reduction does not correct abnormalities due to progranulin haploinsufficiency. |
Q26782984 | Phenotypic Heterogeneity of Monogenic Frontotemporal Dementia |
Q53820484 | Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations: a genome-wide association study. |
Q26863702 | Potential mechanisms of progranulin-deficient FTLD |
Q37293615 | Progranulin Levels in Plasma and Cerebrospinal Fluid in Granulin Mutation Carriers. |
Q37978700 | Progranulin axis and recent developments in frontotemporal lobar degeneration |
Q47966141 | Progranulin plasma levels predict the presence of GRN mutations in asymptomatic subjects and do not correlate with brain atrophy: results from the GENFI study |
Q47623958 | Progranulin: a new avenue towards the understanding and treatment of neurodegenerative disease |
Q36826623 | Progranulin: an emerging target for FTLD therapies |
Q27024421 | Progranulin: at the interface of neurodegenerative and metabolic diseases |
Q37485657 | Promoter DNA methylation regulates progranulin expression and is altered in FTLD. |
Q92381285 | Putative risk alleles for LATE-NC with hippocampal sclerosis in population-representative autopsy cohorts |
Q38015344 | Recent insights into the involvement of progranulin in frontotemporal dementia. |
Q52347550 | Role of Genetics and Epigenetics in the Pathogenesis of Alzheimer's Disease and Frontotemporal Dementia. |
Q35883188 | Similar clinical and neuroimaging features in monozygotic twin pair with mutation in progranulin |
Q93013749 | TDP-43 and Limbic-Predominant Age-Related TDP-43 Encephalopathy |
Q34566756 | TDP-43 in aging and Alzheimer's disease - a review |
Q64217982 | TMEM106B Effect on cognition in Parkinson disease and frontotemporal dementia |
Q35512313 | TMEM106B a novel risk factor for frontotemporal lobar degeneration |
Q44624389 | TMEM106B and APOE polymorphisms interact to confer risk for late-onset Alzheimer's disease in Han Chinese |
Q42845421 | TMEM106B and frontotemporal lobar degeneration: can over-expression tell us how reductions are beneficial? |
Q33746240 | TMEM106B expression is reduced in Alzheimer's disease brains |
Q55455470 | TMEM106B haplotypes have distinct gene expression patterns in aged brain. |
Q37730909 | TMEM106B is a genetic modifier of frontotemporal lobar degeneration with C9orf72 hexanucleotide repeat expansions |
Q37154601 | TMEM106B p.T185S regulates TMEM106B protein levels: implications for frontotemporal dementia |
Q37621660 | TMEM106B protects C9ORF72 expansion carriers against frontotemporal dementia |
Q36307120 | TMEM106B risk variant is implicated in the pathologic presentation of Alzheimer disease |
Q36247028 | TMEM106B, the risk gene for frontotemporal dementia, is regulated by the microRNA-132/212 cluster and affects progranulin pathways |
Q42332631 | TMEM106B: a strong FTLD disease modifier |
Q24314869 | The FTLD risk factor TMEM106B and MAP6 control dendritic trafficking of lysosomes |
Q42089594 | The Lysosomal Trafficking Transmembrane Protein 106B Is Linked to Cell Death |
Q88571271 | The Post-GWAS Era: From Association to Function |
Q35153681 | The TMEM106B locus and TDP-43 pathology in older persons without FTLD |
Q38825197 | The clinical spectrum of sporadic and familial forms of frontotemporal dementia. |
Q42962467 | The frontotemporal lobar degeneration risk factor, TMEM106B, regulates lysosomal morphology and function |
Q56594618 | The lysosomal function of progranulin, a guardian against neurodegeneration |
Q36485513 | The molecular basis of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum |
Q37067641 | The role of the innate immune system in Alzheimer's disease and frontotemporal lobar degeneration: an eye on microglia |
Q26998919 | Therapeutic and diagnostic challenges for frontotemporal dementia |
Q38797600 | TiME for TMEM106B |
Q34311246 | Transmembrane protein 106A is silenced by promoter region hypermethylation and suppresses gastric cancer growth by inducing apoptosis |
Q38062966 | Treatment implications of C9ORF72. |
Q42323240 | Unusually long duration and delayed penetrance in a family with FTD and mutation in MAPT (V337M). |
Q38571992 | Update on Hippocampal Sclerosis |
Q38932474 | What we know about TMEM106B in neurodegeneration |
Q37187461 | Where genotype is not predictive of phenotype: towards an understanding of the molecular basis of reduced penetrance in human inherited disease |
Q91962076 | White matter hyperintensities in progranulin-associated frontotemporal dementia: A longitudinal GENFI study |
Q47707736 | miR-34b-5p inhibition attenuates lung inflammation and apoptosis in an LPS-induced acute lung injury mouse model by targeting progranulin. |
Search more.